Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Pain Neuroscience Education Pne

Research Leaders

6 sponsors active, led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT04145518Phase 4CompletedPrimary

Mechanistic Characterization of Uterine Pain

NCT06983600Not ApplicableCompletedPrimary

The Effect of SuJok Application on Dysmenorrhea and Quality of Life in Young People With Primary Dysmenorrhea:

NCT06732778Not ApplicableCompleted

Effectiveness of Pain Neuroscience Education in Women With Menstrual Pain

Showing all 3 trials

Research Network

Common Treatments

  • Pain Neuroscience Education Pne1
  • Alternative Therapysujok Therapy1
  • Control Group Cg1
  • Naproxen Sodium1

Active Sponsors

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • Endeavor Health1
  • Uskudar University1
  • National Institutes of Health (NIH)1
  • Hasan Kalyoncu University1

Top Investigators

Related Conditions

  • Dysmenorrhea Primary1
  • Dysmenorrhea Secondary1
  • Fibroid Uterus1
  • Leiomyoma1
  • Alternative Treatment1

Activity Timeline